Announcement of Fujian Aonong Biotechnology Group Co., Ltd. on the listing and circulation of some restricted shares
Securities code: 603363 Securities abbreviation: Aonong Biotechnology Announcement number: 2025-116
Fujian Aonong Biotechnology Group Co., Ltd.
Announcement on the listing and circulation of some restricted shares
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents in accordance with the law.
Important content reminder:
The type of stock listing this time is other shares (reorganization investment converted into shares); the stock subscription method is offline, and the number of listed shares is 447,000,000 shares.
The total number of shares in circulation this time is 447,000,000.
The listing and circulation date of this stock is December 29, 2025.
1. Type of listing of restricted shares this time
The type of restricted shares listed and circulated by Fujian Aonong Biotechnology Group Co., Ltd. (hereinafter referred to as the "Company") are the converted shares obtained by financial investors during the company's reorganization.
On November 5, 2024, the Zhangzhou Intermediate People's Court of Fujian Province (hereinafter referred to as the "Zhangzhou Intermediate Court" or the "Court") ruled to accept the creditor's application for reorganization of the company, and appointed Shanghai AllBright Law Firm as the company's administrator (hereinafter referred to as the "Administrator"). For details, please refer to the company's announcement on November 6, 2024. The "Announcement on the Court's Ruling to Accept the Company's Reorganization and the Designation of a Manager and the Superimposition of a Delisting Risk Warning on the Company's Stocks" (Announcement Number: 2024-193) was disclosed on the same day.
On December 9, 2024, the Zhangzhou Intermediate People's Court ruled to approve the "Reorganization Plan of Fujian Aonong Biotechnology Group Co., Ltd." and terminated the company's reorganization procedures. For details, please refer to the "Announcement on the Company's Reorganization Plan Approved by the Court's Ruling" disclosed by the company on December 11, 2024 (Announcement Number: 2024-212).
According to the reorganization plan, the company's total share capital of 870,274,742 shares will be deducted from the limit of repurchase and cancellation.
The base number is 867,653,942 shares after 2,620,800 shares of statutory stock, and the shares are converted into 20 shares for every 10 shares.
Capital reserves were transferred to share capital, with a total of 1,735,307,884 shares transferred. The above-mentioned transfer of shares will not be carried out to the original shareholders.
All were distributed and disposed of in accordance with the provisions of the reorganization plan, of which 1,005,000,000 shares were converted into additional shares
Transferred by the restructuring investors, the remaining 730,307,884 converted shares were used to pay off the company's debts.
On December 25, 2024, the company completed the transfer of 1,735,307,884 shares for the purpose of implementing the reorganization plan
Transfer registration, on December 27, 2024, the court transferred the 847,000,000 limited shares held by the manager’s securities account to
The conditional shares are transferred to the securities account of the reorganization investor and registered with China Securities Depository and Clearing Co., Ltd.
The company's Shanghai branch has completed the transfer registration procedures. The specific number of shares held by each reorganization investor and the lock-up period are as follows:
Serial number Investor’s securities account name Number of shares held (shares) Lock-up period
Quanzhou Aofa Tongxin Equity Investment Management Partnership
1 200,000,000 36 months
(limited partnership)
2 Hubei Provincial Grain Co., Ltd. 70,000,000 36 months 3 Xiamen Guweide Food Co., Ltd. 75,000,000 36 months 4 Gongqingcheng Minhui Investment Partnership (limited partnership) 50,000,000 36 months
Jinjiang Suzino Trading Co., Ltd. (formerly known as "Jinjiang Suzino Trading Co., Ltd.")
5 5,000,000 36 Yuejiang Yongchu Trading Co., Ltd.")
China Foreign Economic and Trade Trust Co., Ltd.-Foreign Trade
6 65,000,000 12-month trust-Xuanwu No. 13 collective fund trust plan
Xiamen International Trust Co., Ltd.-Xiamen Trust-Ao
7 123,000,000 12 months
Chuangzhihe No. 1 Asset Services Trust
8 Beijing Yawen Chunya Technology Development Center (Limited Partnership) 20,000,000 12 months
Shenzhen Jifu Qirui Investment Partnership (Limited Partnership)
9 units) - Jifu Qirui - Tianze No. 1 Private Securities Investment 40,000,000 12-month fund
Suzhou Hongquan Investment Management Co., Ltd.-Hongquan Dingxin
10 14,200,000 12 months M&A and Reorganization No. 1 Private Equity Investment Fund
Lu Shengsheng Private Equity Fund Management (Qingdao) Co., Ltd. -
11 33,900,000 12-month Lu Shengsheng Smart Agriculture Private Securities Investment Fund
Hunan Juyin Private Equity Fund Management Co., Ltd.-Juyin
12 58,450,000 12-month Compound Interest Stable Growth No. 1 Private Securities Investment Fund
Beijing Galaxy Huiqiao No. 1 Enterprise Management Center (Co., Ltd.
13 2,800,000 12 months
Guy)
14 Guangdong Yuecai Asset Management Co., Ltd. 15,000,000 12 months
Shenzhen Zhaoping Lanbo No. 1 Investment Partnership (Limited
15 32,650,000 12 months partnership)
Shenzhen Zhaoping Lanbo No. 2 Investment Partnership (Limited
16 15,000,000 12 months partnership)
Hubei Huachu Guoke No. 2 Investment Partnership (Limited Partnership)
17 10,000,000 12 months
Guy)
18 Quanzhou Longda Digital Technology Co., Ltd. 17,000,000 12 months
Total 847,000,000 --
The restricted shares applied for listing and circulation this time involve a total of 447,000,000 shares held by 13 shareholders (serial numbers 6 to 18 in the above table). The lock-up period is 12 months. The current restriction period is about to expire and will be listed and circulated on December 29, 2025.
2. Changes in the number of shares of the company since the formation of restricted shares until now
On December 25, 2024, after the company completed the transfer registration of the shares transferred to implement the reorganization plan, the total share capital was 2,605,582,626 shares.
On January 24, 2025, the company completed the repurchase and cancellation procedures for 2,620,800 shares of equity incentive restricted shares. The company's total share capital changed from 2,605,582,626 shares to 2,602,961,826 shares. The number of shares applied to be lifted from sales restrictions this time has not changed.
3. Commitments related to the listing and circulation of restricted shares
- Commitments regarding the lifting of restricted shares
Commitment class Commitment start Commitment fulfillment
Name of shareholder Commitment content Commitment period Type Time Situation China’s Foreign Economic and Trade On the date of obtaining restructuring investment converted into shares
Lock-up period Trust Co., Ltd. - Outside 12 months, no transfer or entrustment will be made until December 2024
12 months Normal performance of commitments Trade Trust-Xuanwu No. 13 Others manage its direct and indirect holdings on the 27th of the month
Collective Fund Trust Plan Aonong Biotechnology Co., Ltd.
Xiamen International Trust Co., Ltd. on the date of obtaining shares converted from restructuring investment
Lock-in period December 2024
Company - Xiamen Trust - No transfer or entrustment within 12 months from 12 months Normal performance of commitments 27th of March
Aochuangzhihe No.1 Assets are managed directly and indirectly by others.
Service Trust Aonong Biotechnology Co., Ltd.
On the date of obtaining shares converted from restructuring investment
Beijing Yawen Chunya Technology
Within 12 months from the lock-in period, no transfer or entrustment will be made to the 2024 12 Development Center (limited to 12 months, normal performance of commitments, and others to manage its direct and indirect holdings)
Aonong Biotechnology Co., Ltd.
Shenzhen Jifu Qirui Investment
On the date of obtaining shares converted from restructuring investment
partnership (limited partnership)
Within 12 months from the lock-up period, no transfer or entrustment will be made (12 units in 2024) - Jifu Qirui - Tian 12 months Normal performance of commitments Others manage their direct and indirect holdings Rize No. 1 Private Securities Investment on March 27
Aonong Biotechnology Co., Ltd.
capital fund
Suzhou Hongquan Investment Management on the date of obtaining shares converted from restructuring investment
Lock-up period Co., Ltd.-Hongquan Ding No transfer or entrustment will be made within 12 months from December 2024 12 months Normal performance of commitments
On the day when Lu Shengsheng Private Equity Fund Management obtained the shares converted from the restructuring investment,
The lock-up period will not be transferred or entrusted within 12 months from the Management (Qingdao) Co., Ltd. 12 2024 12 months Normal performance of commitments - Lu Shengsheng Smart Agriculture Others manage its direct and indirect holdings Private securities investment funds Aonong Biotech Co., Ltd.
Hunan Juyin Private Equity Fund obtained the restructuring investment and converted shares into shares on the day
Lock-up period Management Co., Ltd.-Ju will not be transferred or entrusted within 12 months from December 2024
12 months Normal performance of commitment 7 Yin Compound Interest Stable Growth No. 1 Private person manages its direct and indirect securities investment funds raised on 27th Aonong Biotechnology Co., Ltd.
On the date of obtaining shares converted from restructuring investment
Beijing Galaxy Huiqiao No.1
Within 12 months from the lock-in period, no transfer or entrustment will be made to the 2024 12 Enterprise Management Center (limited 12 months to normal performance of commitments, others manage its direct and indirect partnerships held on 27th)
Aonong Biotechnology Co., Ltd.
On the date of obtaining shares converted from restructuring investment
The lock-up period Guangdong Yuecai Asset Management will not transfer or entrust within 12 months from December 2024. 12 months Normal performance of commitments Co., Ltd. Others will manage its directly and indirectly held shares of Aonong Biotech Co., Ltd. on March 27
On the date of obtaining shares converted from restructuring investment
Shenzhen Zhaoping Lanboyi
Within 12 months from the lock-in period, no investment partnership will be transferred or entrusted (there will be a 12-month limited partnership held directly and indirectly by others to manage its direct and indirect holdings).
Aonong Biotechnology Co., Ltd.
On the date of obtaining shares converted from restructuring investment
Shenzhen Zhaoping Lanbo 2
Within 12 months from the lock-in period, no investment partnership will be transferred or entrusted (there will be a 12-month limited partnership held directly and indirectly by others to manage its direct and indirect holdings).
Aonong Biotechnology Co., Ltd.
On the date of obtaining shares converted from restructuring investment
Hubei Huachu Guoke No. 2
Within 12 months from the lock-in period, no investment partnership will be transferred or entrusted in 2024 (limited 12 months to normal performance of commitments, others will manage its direct and indirect holdings of partnerships)
Aonong Biotechnology Co., Ltd.
On the date of obtaining shares converted from restructuring investment
The lock-in period is 12 months from Quanzhou Longda Digital Technology and will not be transferred or entrusted until December 2024.
12 months Normal performance of commitments Technology Co., Ltd. Others manage its direct and indirect holdings on the 27th of the month
Aonong Biotechnology Co., Ltd.
- Fulfillment of commitments
As of the date of this announcement, the above-mentioned 13 shareholders have strictly fulfilled their share lock commitments during the lock-up period, and there is no failure to fulfill relevant commitments that would affect the listing and circulation of this restricted stock.
In addition, according to the "Concerted Action Agreement" signed on December 25, 2024 by China Foreign Economic and Trade Trust Co., Ltd. - Foreign Trade Trust - Xuanwu No. 13 Collective Fund Trust Plan, Xiamen International Trust Co., Ltd. - Xiamen Trust - Aochuang Zhihe No. 1 Asset Service Trust, and Beijing Yawen Chunya Technology Development Center (Limited Partnership), the three parties should act in concert when exercising their shareholder rights such as proposal rights and voting rights as shareholders of the company. The three parties collectively hold 20,800 company shares. million shares, accounting for 7.99% of the company's total share capital, and is a shareholder holding more than 5% of the listed company's shares.
The above-mentioned "Concerted Action Agreement" is valid until twelve months from the date when Aonong Biotech's shares are transferred and registered to the securities accounts designated by the parties. Within six months of the expiration of the concerted action relationship, the three parties shall continue to jointly abide by the relevant provisions on the reduction of holdings by major shareholders in the "Interim Measures for the Management of Share Reductions by Shareholders of Listed Companies" and "Shanghai Stock Exchange Self-Discipline Supervision Guidelines for Listed Companies No. 15 - Share Reductions by Shareholders, Directors and Senior Management Personnel" within six months.
4. Verification opinions of intermediaries
The company’s financial advisor, Cathay Haitong Securities Co., Ltd., issued a verification opinion on the listing and circulation of restricted shares and held that:
The listing and circulation of the company's restricted shares complies with the provisions of the "Company Law of the People's Republic of China", "Securities Law of the People's Republic of China", "Stock Listing Rules of the Shanghai Stock Exchange", "Self-Discipline Supervision Guidelines for Listed Companies of the Shanghai Stock Exchange No. 13 - Bankruptcy and Reorganization and Other Matters" and other laws and administrative regulations;
The number of shares with sales restrictions lifted and the time for listing and circulation comply with relevant laws and administrative regulations.
regulations; regulations
- The financial consultant has no objection to the company’s lifting of sales restrictions on its shares.
5. Listing and circulation of restricted shares this time
The total number of restricted shares circulating in this listing is 447,000,000 shares.
The listing and circulation date of this time is December 29, 2025.
Detailed list of listing and circulation of restricted shares
Hold restricted shares
Number of restricted shares held. Current listing flow. Serial number of remaining restricted shares. Name of shareholder. Total shares of the company.
Volume (shares) Number of shares (shares) Quantity (shares) Capital ratio
China Foreign Economic and Trade Trust Co., Ltd.
1 - Foreign Trade Trust - Xuanwu No. 13 Collective Investment 65,000,000 2.50% 65,000,000 0 gold trust plan
Xiamen International Trust Co., Ltd.-Xiamen Trust
2 123,000,000 4.73% 123,000,000 0 Trust - Aochuang Zhihe No. 1 Asset Service Trust
Beijing Yawen Chunya Science and Technology Development Center (with
3 20,000,000 0.77% 20,000,000 0Limited partnership)
Shenzhen Jifu Qirui Investment Partnership
4 (Limited Partnership) - Jifu Qirui - Tianze 40,000,000 1.54% 40,000,000 0 No. 1 Private Securities Investment Fund
Suzhou Hongquan Investment Management Co., Ltd.-Hong
5 Quandingxin Merger and Reorganization No. 1 Private Equity Investment 14,200,000 0.55% 14,200,000 0 Capital Fund
Lu Shengsheng Private Equity Fund Management (Qingdao) has
6 Co., Ltd. - Lu Shengsheng Smart Agriculture Private Equity Certificate 33,900,000 1.30% 33,900,000 0 Bond Investment Fund
Hunan Juyin Private Equity Fund Management Co., Ltd.
7 - Juyin Compound Interest Stable Growth No. 1 Private Equity Investment Fund 58,450,000 2.25% 58,450,000 0 Capital Fund
Beijing Galaxy Huiqiao No.1 Enterprise Management Center
8 2,800,000 0.11% 2,800,000 0
(limited partnership)
9 Guangdong Yuecai Asset Management Co., Ltd. 15,000,000 0.58% 15,000,000 0
Shenzhen Zhaoping Lanbo No. 1 Investment Partnership
10 32,650,000 1.25% 32,650,000 0 business (limited partnership)
Shenzhen Zhaoping Lanbo No. 2 Investment Partnership
11 15,000,000 0.58% 15,000,000 0 Industry (Limited Partnership)
Hubei Huachu Guoke No. 2 Investment Partnership
12 10,000,000 0.38% 10,000,000 0
(limited partnership)
13 Quanzhou Longda Digital Technology Co., Ltd. 17,000,000 0.65% 17,000,000 0
Total 447,000,000 17.17% 447,000,000 0
- List of listing and circulation of restricted shares
Serial number Type of restricted shares Number of shares in circulation in this listing (shares)
1 Others 447,000,000
Total – 447,000,000
6. Share capital change structure table
Unit: Class of shares Before the change Number of changes After the change Circulating shares with selling restrictions 1,005,000,000 -447,000,000 558,000,000 Circulating shares with no selling conditions 1,597,961,826 447,000,000 2,044,961,826
Total shares 2,602,961,826 0 2,602,961,826
Announcement is hereby made.
Board of Directors of Fujian Aonong Biotechnology Group Co., Ltd.
December 24, 2025